Intensification of antiretroviral treatment with raltegravir for late-presenting HIV-infected pregnant women

被引:0
|
作者
Thepnarong, N. [1 ]
Puthanakit, T. [1 ]
Chaithongwongwatthana, S. [2 ]
Anugulruengkitt, S. [1 ]
Anunsittichai, O. [3 ]
Theerawit, T. [3 ]
Pancharoen, C. [1 ]
Phanuphak, P. [4 ]
机构
[1] Chulalongkorn Univ, Res Unit Pediat Infect Dis & Vaccines, Dept Pediat, Fac Med, Bangkok, Thailand
[2] Chulalongkorn Univ, Dept Obstet & Gynecol, Res Unit Pediat Infect Dis & Vaccines, Fac Med, Bangkok, Thailand
[3] Chulalongkorn Univ, Res Unit Pediat Infect Dis & Vaccines, Fac Med, Bangkok, Thailand
[4] Thai Red Cross AIDS Res Ctr, Bangkok, Thailand
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
WEAC0202
引用
收藏
页码:59 / 59
页数:1
相关论文
共 50 条
  • [1] Raltegravir versus lopinavir/ritonavir for treatment of HIV-infected late-presenting pregnant women
    Brites, Carlos
    Nobrega, Isabella
    Luz, Estela
    Travassos, Ana Gabriela
    Lorenzo, Cynthia
    Netto, Eduardo M.
    [J]. HIV CLINICAL TRIALS, 2018, 19 (03): : 94 - 100
  • [2] Short Communication: Use of Raltegravir in Late-Presenting HIV-Infected Pregnant Women
    Nobrega, Isabella
    Travassos, Ana Gabriela
    Haguihara, Tatiana
    Amorim, Fabio
    Brites, Carlos
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2013, 29 (11) : 1451 - 1454
  • [3] Efficacy of raltegravir in late-presenting HIV-infected pregnant women: a case series presentation
    Nobrega, I
    Travassos, A.
    Haguihara, T.
    Brites, C.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 116 - 116
  • [4] Antiretroviral therapy containing raltegravir in HIV-infected pregnant women. Systematic review
    Garia-Fernandez, Lisset
    Fiestas, Fabian
    Vasquez, Ruben
    Benites, Carlos
    [J]. REVISTA CHILENA DE INFECTOLOGIA, 2016, 33 : S60 - S66
  • [5] VIRAL SUPPRESSION IN LATE PRESENTING HIV-INFECTED PREGNANT WOMEN
    Xavier-Souza, E.
    Nobrega, I.
    Limbo, M. S.
    Barone, C.
    Fernandes, S.
    Nello, E.
    Travassos, A. G.
    [J]. SEXUALLY TRANSMITTED INFECTIONS, 2017, 93 : A120 - A121
  • [6] Intensification of antiretroviral treatment with raltegravir for pregnant women living with HIV at high risk of vertical transmission
    Puthanakit, Thanyawee
    Thepnarong, Nattawan
    Chaithongwongwatthana, Surasith
    Anugulruengkitt, Suvaporn
    Anunsittichai, Orawan
    Theerawit, Tuangtip
    Ubolyam, Sasiwimol
    Pancharoen, Chitsanu
    Phanuphak, Praphan
    [J]. JOURNAL OF VIRUS ERADICATION, 2018, 4 (02) : 61 - 65
  • [7] Antiretroviral therapy for pregnant HIV-infected women
    Luber, AD
    Dong, BJ
    [J]. ANNALS OF INTERNAL MEDICINE, 2000, 132 (06) : 509 - 509
  • [8] Adherence to antiretroviral treatment among pregnant and postpartum HIV-infected women
    Mellins, C. A.
    Chu, C.
    Malee, K.
    Allison, S.
    Smith, R.
    Harris, L.
    Higgins, A.
    Zorrilla, C.
    Landesman, S.
    Serchuck, L.
    LaRussa, P.
    [J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2008, 20 (08): : 958 - 968
  • [9] Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation
    Aziz, N.
    Sokoloff, A.
    Kornak, J.
    Leva, N. V.
    Mendiola, M. L.
    Levison, J.
    Feakins, C.
    Shannon, M.
    Cohan, D.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2013, 120 (12) : 1534 - 1547
  • [10] Bictegravir pharmacokinetics in a late-presenting HIV-1-infected pregnant woman: a case report
    Le, Minh Patrick
    Ferre, Valentine Marie
    Mazy, Fabienne
    Bourgeois-Moine, Agnes
    Damond, Florence
    Matheron, Sophie
    Descamps, Diane
    Ghosn, Jade
    Peytavin, Gilles
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (03) : 851 - 853